<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03776617</url>
  </required_header>
  <id_info>
    <org_study_id>ScalCran</org_study_id>
    <nct_id>NCT03776617</nct_id>
  </id_info>
  <brief_title>Scalp Block in Elective Craniotomy for Tumor Dissection Trial</brief_title>
  <official_title>Regional Scalp Block With Ropivacaine 0.5% in Patients Undergoing Elective Craniotomy: a Prospective Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>George Papanicolaou Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>George Papanicolaou Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study was designed to evaluate the effect of scalp block combined with general&#xD;
      anesthesia on the intraoperative consumption of fentanyl and time of extubation of patients&#xD;
      undergoing elective craniotomy. Scalp block will be applied to three groups with differences&#xD;
      of the administered solution to the scalp and one group will be placebo group.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Regional scalp block (RSB) is an established technique that involves infiltration of local&#xD;
      anesthetic (LA) at well-defined anatomical sites targeting the major sensory innervation of&#xD;
      the scalp. Regional techniques minimize anesthetic requirements and their effects may be&#xD;
      beneficial. There is a lack of consensus and evidence concerning alternative analgesia&#xD;
      strategies for cranial neurosurgery.&#xD;
&#xD;
      Patients undergoing elective craniotomy for tumor dissection will be randomly divided into&#xD;
      four groups to receive scalp block as an adjuvant to general anesthesia. After a standard&#xD;
      induction sequence using propofol, fentanyl and a single dose of rocuronium, patients will be&#xD;
      intubated. Bilateral scalp block will be given immediately after induction, except patients&#xD;
      in control group who will not have a scalp block. Drugs for scalp block will be 20ml&#xD;
      ropivacaine 0.5%, 20ml xylocaine 1% and dexmedetomidine 1mcg/kg.Anaesthesia will be&#xD;
      maintained with propofol and remifentanyl infusion. Intraoperatively, propofol infusion at 75&#xD;
      to 100 μg/kg/h up to dura closure and reduced to 50-75 μg/kg/h up to skin closure. Five&#xD;
      minutes before head pinning scalp block was performed by blocking the supraorbital,&#xD;
      supratrochlear, auriculotemporal, occipital, and postauricular branches of the greater&#xD;
      auricular nerves.Routine monitoring of electrocardiogram, heart rate (HR), and mean arterial&#xD;
      blood pressure (MAP) will record at two-minute intervals from the beginning of anesthesia&#xD;
      until 10 minutes after incision, followed by 5-minute intervals throughout the remaining&#xD;
      course of the surgery. Monitoring of the depth of anesthesia will also performed using the&#xD;
      Bispectral Index. Sample size was calculated based on Type I error of α = 5% and power = 80%&#xD;
      and minimum difference d = 30%, which is clinically significant in the pilot study. All&#xD;
      quantitative variables will be reported as mean and standard deviation, and qualitative&#xD;
      variables will be listed as number (percentage). Mann-Whitney test and Chi-square test will&#xD;
      be used for comparison of endpoints. Linear mixed model will be used to evaluate the&#xD;
      differences of hemodynamics variables. Statistical Package for Social Sciences (SPSS, version&#xD;
      19.0; SPSS Inc., Chicago, USA) will be used for all calculations. p values less than .05 will&#xD;
      be considered significant.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date type="Actual">January 5, 2019</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">November 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>intraoperative opioid consumption</measure>
    <time_frame>intraoperative</time_frame>
    <description>The overall intravenous fentanyl and remifentanil consumption (microgram/ kilogram) during the surgery. The decision to administer fentanyl is guided by the changes of blood pressure and/ or heart rate greater than 20% from baseline level.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>systolic arterial pressure and diastolic arterial pressure</measure>
    <time_frame>intraoperative</time_frame>
    <description>The systolic and diastolic blood pressure and heart rate change from baseline will be calculated. The unit for blood pressure is mmHg.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>heart rate fluctuation</measure>
    <time_frame>intraoperative</time_frame>
    <description>heart rate change from baseline will be calculated. The unit for heart rate is bpm</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>extubation time</measure>
    <time_frame>one day</time_frame>
    <description>Time from the end of anesthetic to fully awake and extubation</description>
  </secondary_outcome>
  <other_outcome>
    <measure>chronic pain after craniotomy</measure>
    <time_frame>3 months after craniotomy</time_frame>
    <description>telephone after 3 months and ask for pain description using the Numeric Pain Rating Scale (NPRS). A respondent selects a whole number (0-10 integers) that best reflects the intensity of his/her pain.The 11-point numeric scale ranges from '0' representing one pain extreme (e.g. &quot;no pain&quot;) to '10' representing the other pain extreme (e.g. &quot;pain as bad as you can imagine&quot; or &quot;worst pain imaginable&quot;).</description>
  </other_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Craniotomy</condition>
  <arm_group>
    <arm_group_label>Group Ropivacaine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>general anesthesia + scalp block with 20 ml xylocaine 1% and 20ml ropivacaine 0.5%</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group Ropivacaine-Dexmedetomidine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>general anesthesia + scalp block with 20 ml xylocaine 1%, 20ml ropivacaine 0.5% and 1mcg/kg dexmedetomidine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>general anesthesia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group sham</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>general anesthesia + Scalp block with 40ml Normal Saline</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>scalp block</intervention_name>
    <description>Scalp block will be performed five minutes before head pinning for elective craniotomy by blocking supraorbital, auriculotemporal, occipital and postauricular branches of the greater auricular nerves.</description>
    <arm_group_label>Group Ropivacaine</arm_group_label>
    <arm_group_label>Group Ropivacaine-Dexmedetomidine</arm_group_label>
    <arm_group_label>Group sham</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  patients with American Society of Anesthesiologists Physical status classification 1-3&#xD;
&#xD;
          -  patients who are scheduled for elective craniotomy for brain tumor&#xD;
&#xD;
          -  patients who have provided consent for participation in the study&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients who have allergy to local anesthetics and dexmedetomidine&#xD;
&#xD;
          -  Glasgow coma scale &lt;15&#xD;
&#xD;
          -  tumor&gt;4cm&#xD;
&#xD;
          -  any contraindication for receiving dexmedetomidine&#xD;
&#xD;
          -  severe mental impairment&#xD;
&#xD;
          -  pregnant women&#xD;
&#xD;
          -  uncontrolled hypertension, arrhythmia, coagulation disorder&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anastasia Trikoupi, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>General Hospital of Thessaloniki</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Chrysoula Stachtari, MD, PhD</last_name>
    <phone>+306946140458</phone>
    <email>chryssastachtari@yahoo.gr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Zoi Stergiouda, MD</last_name>
    <phone>+306942403938</phone>
    <email>zstergiouda@yahoo.gr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>George Papanikoalou Hospital</name>
      <address>
        <city>Thessaloníki</city>
        <zip>57010</zip>
        <country>Greece</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chrysoula Stachtari, MD, PhD</last_name>
      <email>chryssastachtari@yahoo.gr</email>
    </contact>
    <contact_backup>
      <last_name>Zoi Stergiouda, MD</last_name>
      <email>zstergiouda@yahoo.gr</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Greece</country>
  </location_countries>
  <verification_date>December 2018</verification_date>
  <study_first_submitted>May 16, 2018</study_first_submitted>
  <study_first_submitted_qc>December 12, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">December 17, 2018</study_first_posted>
  <last_update_submitted>August 29, 2019</last_update_submitted>
  <last_update_submitted_qc>August 29, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">September 3, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>George Papanicolaou Hospital</investigator_affiliation>
    <investigator_full_name>Stachtari Chrysoula MD, PhD</investigator_full_name>
    <investigator_title>Stachtari Chrysoula, Consultant Anesthesiologist, G. Papanikolaou Hospital</investigator_title>
  </responsible_party>
  <keyword>scalp block</keyword>
  <keyword>craniotomy</keyword>
  <keyword>dexmedetomidine</keyword>
  <keyword>ropivacaine</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

